Internal Medicine Resident Perspectives Regarding Broad-Spectrum Antibiotic Usage. by Laake, Ann M et al.
Himmelfarb Health Sciences Library, The George Washington University
Health Sciences Research Commons
Medicine Faculty Publications Medicine
Spring 2017










Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs
Part of the Pharmaceutical Preparations Commons
This Journal Article is brought to you for free and open access by the Medicine at Health Sciences Research Commons. It has been accepted for
inclusion in Medicine Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please
contact hsrc@gwu.edu.
APA Citation
Laake, A., Bernabe, G., Peterson, J., & Liappis, A. (2017). Internal Medicine Resident Perspectives Regarding Broad-Spectrum
Antibiotic Usage.. Open Forum Infectious Diseases, 4 (2). http://dx.doi.org/10.1093/ofid/ofx060
BRIEF REPORT • OFID • 1
Open Forum Infectious Diseases
B R I E F  R E P O R T
Internal Medicine Resident 
Perspectives Regarding Broad-
Spectrum Antibiotic Usage
Ann M. Laake,1,2 Gayle Bernabe,3 James Peterson,3 and Angelike P. Liappis1,2
1Section of Infectious Diseases, Medical Service, Veterans Affairs Medical Center, 
Washington, DC; 2Department of Medicine, George Washington University Medical Center, 
Washington, DC; and 3George Washington University School of Public Health, Washington, DC
Focus groups held with internal medicine residents discussed 
their perspectives regarding broad-spectrum antibiotic (BSA) 
usage. Residents knew of BSA-associated adverse events, but 
they did not associate such events with increased patient mor-
bidity and mortality, and they were more likely to use BSA in 
situations with diagnostic uncertainty and sick patients.
Keywords. antimicrobial stewardship; broad-spectrum 
antibiotic usage; qualitative research; resident education.
 
Prescribing antibiotics is a complex behavior influenced by 
national and local culture and individual behavior patterns 
[1]. Qualitative research has explored these influences [2]. 
Understanding influences affecting initiation of broad-spec-
trum antibiotic (BSA) coverage is crucial in developing effective 
antimicrobial stewardship programs.
In academic training centers in the United States, internal 
medicine residents (IMRs) supervised by attending physicians 
typically prescribe antibiotics. The American College of Graduate 
Medical Education (ACGME) has implemented the “Milestone” 
program, a competency-based system requiring IMRs to manage 
“patients with progressive responsibility and independence” [3].
This system makes IMRs ideal targets for stewardship inter-
ventions because they are responsible for most antibiotic pre-
scriptions while also forming prescribing habits. An estimated 
37% of such prescriptions are inappropriate; optimizing them 
could decrease rates of Clostridium difficile infection (CDI) and 
mitigate selective pressure contributing to antimicrobial resist-
ance [4–6]. Utilizing qualitative methodology, we examined 
motivations for prescribing empiric coverage and perceptions 
regarding BSA usage in IMRs in a US hospital.
METHODS
Setting and Subjects
The study occurred between February and September 2013 
at the Washington, DC Veterans Affairs Medical Center 
(DCVAMC), an urban 180-bed tertiary care teaching hospital. 
Participants were selected from IMRs in postgraduate years 
(PGYs) 1–3, working on general medicine or elective rotations 
from 4 academic residency programs (ARPs) affiliated with 
the DCVAMC. The Medical Service Office provided lists of all 
IMRs meeting the selection criteria. Study participant IMRs 
consented knowing that their responses would be recorded 
anonymously and transcribed pseudonymously. Approvals 
from the DCVAMC Institutional Review Board and Research 
and Development Committee were obtained before beginning 
the study. Internal Medicine Program Directors from each affil-
iated ARP also approved its program’s IMRs’ participation. The 
DCVAMC had no antimicrobial stewardship program during 
the focus groups but has subsequently developed one.
Qualitative Methodology
Seven semistructured focus group sessions were conducted. 
Data saturation was achieved by the sixth focus group session. 
Focus groups were chosen over individual interviews due to 
scheduling, efficiency, and convenience for both participants 
and researchers. Weekly focus group sessions contained 10 
to 12 IMRs and met for 2 discussions at the DCVAMC. An 
Infectious Disease fellow (A.M.L.) moderated each discussion. 
A fellow was selected to moderate (1) because of knowledge 
and language considerations required to guide the discussions 
and (2) for the comfort of the participants in discussing topics 
with a peer.
Focus group sessions comprised IMR participants and the 
moderator engaging in a semistructured (Supplementary Data) 
question-and- answer period followed by a clinical vignette-
guided discussion. Sessions were recorded on an audio-MP3 
player. Recordings were then transcribed into Microsoft Word, 
and transcription data was imported into Atlas TI, a qualitative 
research analysis program (Atlas TI 2014, Berlin).
Quantitative Data
Demographic data, including PGYs, genders, and ARP enroll-
ments, were collected for all IMRs at each focus group ses-
sion. The researchers conducted all analyses with χ2, 2-tailed 
tests, accepting a P value of <.05 (SPSS, version 21; SPSS Inc., 
Chicago, IL).
Qualitative Analysis
Three researchers (A.M.L., G.B., and J.P.) first reviewed the 
initial transcripts together and developed codes through 
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consensus. Codes were then applied to the transcripts by 
each researcher individually. Next, researchers met col-
lectively to compare individual coding applications and 
achieve group consensus. Finally, a content analysis of the 
group’s consensus codes was used to develop emergent-spe-
cific themes (Table 1). The frequency of responses represent 
unique responses given by individual study participants to 
which researchers applied that code over the course of the 
recorded sessions.
RESULTS
Forty-eight IMRs participated over the 8-month study period; 
no IMRs declined to participate in the focus groups. Sixty per-
cent of the participants were PGY-1, 17% were PGY-2, and 
23% were PGY-3 IMRs. Fifty-four percent of participants were 
female. Researchers found no difference in the frequency with 
which specific codes were identified among the 4 ARPs (data 
not shown). The PGY-2 participants contributed proportionally 
more comments than participants from other years (PGY-2: 11 
quotes per IMR; PGY-3: 8 quotes per IMR; PGY-1: 5 quotes per 
IMR; P <  .0001); however, researchers found no difference in 
the frequency with which specific codes were identified among 
the different years.
Themes Identified From Focus Group Participant Analysis
Theme 1: Factors That Influenced Broad Spectrum Antibiotics Use by 
Internal Medicine Residents
The IMRs cited many different influences in their responses 
(64 responses) related to decisions about BSA usage, includ-
ing epidemiological risk factors for resistant bacteria, appease-
ment of patients and attending physicians, fear of liability, and 
even convenience. However, the 2 most commonly mentioned 
influences were diagnostic uncertainty (22 responses) and fear 
regarding how “sick” the IMR perceived the patient to be (22 
responses).
Theme 2: Consequences of Antibiotic Spectrum Choice
There were also many responses about the consequences of 
antibiotic spectrum choice (22 responses). Patient morbidity 
Table 1. Themes
Theme Frequency of Responses Representative Quotes
Factors that increase 
broad-spectrum antibiotic 
(BSA) usage by internal medi-
cine residents (IMRs)
Frequently in responses:  
Diagnostic uncertainty; patients perceived 
to be clinically “sick.”
Infrequently in responses:  
Epidemiological risk factors; appeasement 
of attending physician or family members; 
liability concerns; convenience.
“The less you know about the patient, [the] more inclined you are to want to 
cover broadly; so, night-float would [cover] if someone became febrile over-
night, or becomes toxic, or [if] for whatever reason they are more inclined to 
start something broader.” – Postgraduate Year (PGY)-1
“I mean, I don’t consider that guidelines always apply if you don’t have a good 
source.” – PGY-2
“So to be honest, I would probably just start [vancomycin] and [piperacillin-ta-
zobactam] because he is, you know, he meets a few [systemic inflammatory 
response syndrome] criteria, and I don’t think there is any reason [to pre-
scribe] too narrowly when they look like they are that sick.” – PGY-1
“I mean, one of the reasons we might escalate when we don’t need to is, like, 
the clinical context, like maybe this patient looks sick or something, like, by 
the book, and the pharmacists I am sure know the guidelines better than we 
do, [but] it’s the clinical context that alters our clinical judgement.” – PGY-1
Consequences of antibiotic 
spectrum choice
Frequently in responses: 
Consequences for overly narrow coverage 
frequently included patient morbidity and 
mortality.
Infrequently in responses: 
Antibiotic resistance as a consequence for 
both overly broad and overly narrow antibi-
otic spectrums.
Clostridium difficile as a consequence of overly 
broad-spectrum antibiotic use.
Never in responses: 
Patient morbidity and mortality mentioned 
as a consequence of broad-spectrum anti-
biotic use.
“Bacteremia, death, it depends… your patient has florid [pyleonephritis], and 
you are worried they are bacteremic, and you give them [ciprofloxocin], then 
you may have just killed the person.” – PGY-2
“Aside from treatment failure, [the infection] can progress; the patient can 
become septic and have treatment complications from sepsis…” – PGY-1
“I guess, in theory, it could increase resistance later, and broad spectrums 
cause more [Clostridium difficile] and things like that.” – PGY-2
The IMR role in antibiotic
prescription
Frequently in responses: 
IMR writes the initial antibiotic prescription, 
with little subsequent attending physician 
intervention.
Infrequently in responses: 
Occasional subsequent attending physician 
intervention in antibiotic prescription after 
IMR has written the initial prescription.
Never in responses: 
Attending physician writes initial antibiotic 
order.
“That would be me as a resident… I am usually doing more of the admitting 
because I am overnight, and I usually choose the empiric antibiotic coverage, 
and my attending [physician], I am usually able to justify my choice to my 
attending [physician], most of the time my attending [physician] does not 
switch it.” – PGY-2
“I think it always gets run by the resident before it gets written; it doesn’t 
always get run by the attending [physician] before it gets written.” – PGY-2
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and mortality was discussed in the responses, but this was asso-
ciated exclusively with choosing too narrow of an antibiotic 
spectrum (8 responses). The IMRs connected the immediate 
consequences of inappropriately narrow-spectrum antibiotic 
use and inadequate coverage of a patient’s causative bacterial 
organism with progressive infection, and they identified clinical 
decompensation and mortality as ultimate outcomes. However, 
although IMRs identified the immediate consequences of 
unnecessarily BSA use, including CDIs and increased risk of 
antibiotic-resistant infections in the future, they did not con-
nect such adverse events with increased morbidity or mortality 
in their patients.
Theme 3: The Role of Internal Medicine Residents in Inpatient 
Antibiotic Prescription
The IMRs consistently reported responsibility for making ini-
tial decisions regarding both which antibiotics to use and when 
to begin antibiotic treatment for hospitalized patients. In their 
responses (20 responses), none indicated that attending phy-
sicians wrote initial prescriptions more frequently than IMRs. 
Furthermore, the majority of their responses indicated that they 
believed their attending physicians rarely changed their initial 
antibiotic prescriptions.
DISCUSSION
Qualitative methods were used to examine the decision-making 
framework for inpatient BSA usage among US medical train-
ees. In their risk assessment of antibiotic spectrum decisions, 
IMRs associated prescribing an overly narrow antibiotic spec-
trum with clinical morbidity and mortality. Although they cor-
rectly identified increased antimicrobial resistance and CDIs 
as potential consequences of overly broad antibiotic spectrum 
usage, they did not correlate those consequences with mor-
bidity and mortality. It is possible that IMRs independently 
understand that multidrug-resistant organisms or CDIs lead 
to significant patient morbidity and mortality; such knowledge 
was not assessed in our focus groups. Regardless, they do not 
appear to make the transitive jump from unnecessary BSA usage 
to increased patient morbidity and mortality via antimicrobial 
resistance and CDI. Antimicrobial stewardship programs should 
comprehensively educate IMRs on the risks of antibiotic use 
and encourage them to consider the risks of increased antimi-
crobial resistance and CDI when prescribing BSAs. The Centers 
for Disease Control and Prevention has invested resources 
into highlighting the dangers of antimicrobial resistance and 
its negative consequences, both to physicians and to patients 
directly (via the 2013 Report on Antimicrobial Resistance and 
the ongoing “Get Smart” campaign, respectively) [7, 8]. At an 
institutional level, attending physicians should highlight cases 
of antimicrobial resistance and CDIs, along with the antibiotic 
histories of the patients so affected. Trainees should be made 
aware of the antibiotic usage rates of their institution and its 
rates of antimicrobial resistance and CDI, and they should also 
be encouraged to regularly re- evaluate the risks and benefits of 
ongoing antibiotic treatment.
Regarding other findings, participants perceived that their 
attending physicians changed their initial antibiotic choices infre-
quently, making the IMRs the primary decision makers on their 
teams’ antibiotic usage. Such perceptions are consistent with the 
ACGME—Residency Review Committee—Internal Medicine 
Guidelines, which state that “[a]s residents gain experience and 
demonstrate growth in their ability to care for patients, they 
assume roles that permit them to exercise those skills with greater 
independence” [3]. However, these perceptions are at odds with 
qualitative research from the United Kingdom and other European 
countries, in which junior-level physicians did not believe their 
opinions had an effect on final antibiotic prescriptions [9].
Participants were more likely to prefer BSAs in situations 
containing diagnostic uncertainty; similar findings have been 
noted for outpatient antibiotic prescriptions [10, 11]. They were 
also more likely to recommend BSAs in situations in which the 
patient appeared to be clinically unstable or perceived as “sick”, 
consistent with results of previous qualitative studies [6].
Strengths of this study include it (1) highlighting differences 
between US and non-US training systems and (2) being one of 
the first studies to gather qualitative data on antibiotic usage 
from US IMRs. Weaknesses include (1) uncertainty regarding 
how participants’ perceptions on inpatient antibiotic prescrip-
tion relate to their antibiotic prescription habits in clinical set-
tings and (2) lack of input from their attending physicians.
CONCLUSIONS
In conclusion, there is a dual opportunity for antimicrobial 
stewardship programs targeting trainees. Educators can provide 
IMRs with a comprehensive understanding of risks associated 
with antibiotic usage to influence their nascent prescription 
habits, while also affecting current prescription rates.
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